Results
1
-
2
of
2
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
,
BMC Cancer
[DOI: 10.1186/s12885-016-2982-x]
Optimising the Delivery of Tubulin Targeting Agents through Antibody Conjugation
,
Pharmaceutical Research
[DOI: 10.1007/s11095-012-0810-9]